Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Manuka Honey in Tympanoplasty
NCT05657717Phase 3Completed
- Sponsor
- Faculty of Medicine, Universitas Indonesia
- Start
- Jul 2021
- Primary completion
- Sep 2022
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Manukapli in chronic suppurative otitis media (CSOM) (2 arms), sponsored by Faculty of Medicine, Universitas Indonesia. Primary endpoints: Brainstem Evoked Response Audiometry at 5 weeks and Audiometry at 6 weeks. Started Jul 2021; status: completed.
02
Drugs
Manukapli
03
Conditions
chronic suppurative otitis media (CSOM)
Beyond the preview
Go deeper on NCT05657717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05657717.